+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Congestive Heart Failure Treatment Device Market by Product (Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker), End-User (Ambulatory Surgery Center, Hospitals & Clinics) - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995113
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Congestive Heart Failure Treatment Device Market size was estimated at USD 12.44 billion in 2023, USD 13.44 billion in 2024, and is expected to grow at a CAGR of 8.16% to reach USD 21.54 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Congestive Heart Failure Treatment Device Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Congestive Heart Failure Treatment Device Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Congestive Heart Failure Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc.

Market Segmentation & Coverage

This research report categorizes the Congestive Heart Failure Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cardiac Resynchronization Therapy
      • Cardiac Resynchronization Therapy-Defibrillator
      • Cardiac Resynchronization Therapy-Pacemaker
    • Implantable Cardioverter Defibrillator
      • Subcutaneous Implantable Cardioverter Defibrillator
      • Transvenous Implantable Cardioverter Defibrillator
    • Pacemaker
    • Ventricular Assist Device
      • Biventricular Assist Device
      • Left Ventricular Assist Device
      • Right Ventricular Assist Device
  • End-User
    • Ambulatory Surgery Center
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Congestive Heart Failure Treatment Device Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Congestive Heart Failure Treatment Device Market?
  3. What are the technology trends and regulatory frameworks in the Congestive Heart Failure Treatment Device Market?
  4. What is the market share of the leading vendors in the Congestive Heart Failure Treatment Device Market?
  5. Which modes and strategic moves are suitable for entering the Congestive Heart Failure Treatment Device Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Congestive Heart Failure Treatment Device Market

What is the estimated value of the Global Congestive Heart Failure Treatment Device Market?

The Global Congestive Heart Failure Treatment Device Market was estimated to be valued at $13.44 Billion in 2024.

What is the growth rate of the Global Congestive Heart Failure Treatment Device Market?

The growth rate of the Global Congestive Heart Failure Treatment Device Market is 8.1%, with an estimated value of $21.54 Billion by 2030.

What is the forecasted size of the Global Congestive Heart Failure Treatment Device Market?

The Global Congestive Heart Failure Treatment Device Market is estimated to be worth $21.54 Billion by 2030.

Who are the key companies in the Global Congestive Heart Failure Treatment Device Market?

Key companies in the Global Congestive Heart Failure Treatment Device Market include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc. and St. Jude Medical, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Congestive Heart Failure Treatment Device Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
5.1.1.2. Increasing focus on early and primary diagnosis of heart-related disorders
5.1.1.3. Government initiatives spreading awareness on cardiovascular diseases
5.1.2. Restraints
5.1.2.1. Relatively expensive devices and preference for drugs
5.1.3. Opportunities
5.1.3.1. Rising government approvals for CHF devices
5.1.3.2. Technological advancements in CHF treatment devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory approval process
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Congestive Heart Failure Treatment Device Market, by Product
6.1. Introduction
6.2. Cardiac Resynchronization Therapy
6.3.1. Cardiac Resynchronization Therapy-Defibrillator
6.3.2. Cardiac Resynchronization Therapy-Pacemaker
6.3. Implantable Cardioverter Defibrillator
6.4.1. Subcutaneous Implantable Cardioverter Defibrillator
6.4.2. Transvenous Implantable Cardioverter Defibrillator
6.4. Pacemaker
6.5. Ventricular Assist Device
6.6.1. Biventricular Assist Device
6.6.2. Left Ventricular Assist Device
6.6.3. Right Ventricular Assist Device
7. Congestive Heart Failure Treatment Device Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgery Center
7.3. Hospitals & Clinics
8. Americas Congestive Heart Failure Treatment Device Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Congestive Heart Failure Treatment Device Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Congestive Heart Failure Treatment Device Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abiomed, Inc.
12.1.2. Berlin Heart GmbH
12.1.3. Biotronik SE & Co. KG
12.1.4. Boston Scientific Corporation
12.1.5. HeartWare International, Inc.
12.1.6. Jarvik Heart, Inc.
12.1.7. LivaNova PLC
12.1.8. Medtronic plc
12.1.9. ReliantHeart Inc.
12.1.10. St. Jude Medical, Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET RESEARCH PROCESS
FIGURE 2. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
FIGURE 3. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET DYNAMICS
FIGURE 7. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • ReliantHeart Inc.
  • St. Jude Medical, Inc.

Methodology

Loading
LOADING...